{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:36:39Z","timestamp":1780572999289,"version":"3.54.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s42000-024-00603-5","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T02:02:18Z","timestamp":1730340138000},"page":"179-188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical utility of anti-M\u00fcllerian hormone in female children and adolescents"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5263-9207","authenticated-orcid":false,"given":"Effrosyni","family":"Birbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5460-3323","authenticated-orcid":false,"given":"Anastasia","family":"Vatopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4430-0588","authenticated-orcid":false,"given":"Theofilos","family":"Kanavos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6118-9706","authenticated-orcid":false,"given":"Kyriakos","family":"Birmpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chara","family":"Skentou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Zikopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7164-8603","authenticated-orcid":false,"given":"Fani","family":"Gkrozou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"key":"603_CR1","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humupd\/dmt062","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, Griesinger G, Kelsey TW, La Marca A, Lambalk C, Mason H, Nelson SM, Visser JA, Wallace WH, Anderson RA (2014) The physiology and clinical utility of anti-mullerian hormone in women. Hum Reprod Update 20:370\u2013385. https:\/\/doi.org\/10.1093\/humupd\/dmt062","journal-title":"Hum Reprod Update"},{"key":"603_CR2","doi-asserted-by":"publisher","first-page":"1273966","DOI":"10.3389\/fendo.2023.1273966","volume":"14","author":"A Iwase","year":"2023","unstructured":"Iwase A, Hasegawa Y, Tsukui Y, Kobayashi M, Hiraishi H, Nakazato T, Kitahara Y (2023) Anti-M\u00fcllerian hormone beyond an ovarian reserve marker: the relationship with the physiology and pathology in the life-long follicle development. Front Endocrinol (Lausanne) 14:1273966. https:\/\/doi.org\/10.3389\/fendo.2023.1273966","journal-title":"Front Endocrinol (Lausanne)"},{"key":"603_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/GCO.0000000000000087","volume":"26","author":"B Leader","year":"2014","unstructured":"Leader B, Baker VL (2014) Maximizing the clinical utility of antim\u00fcllerian hormone testing in women\u2019s health. Curr Opin Obstet Gynecol 26:226\u2013236. https:\/\/doi.org\/10.1097\/GCO.0000000000000087","journal-title":"Curr Opin Obstet Gynecol"},{"key":"603_CR4","doi-asserted-by":"publisher","first-page":"pgac182","DOI":"10.1093\/pnasnexus\/pgac182","volume":"1","author":"F Zhao","year":"2022","unstructured":"Zhao F, Grimm SA, Jia S, Yao HH-C (2022) Contribution of the wolffian duct mesenchyme to the formation of the female reproductive tract. PNAS Nexus 1:pgac182. https:\/\/doi.org\/10.1093\/pnasnexus\/pgac182","journal-title":"PNAS Nexus"},{"key":"603_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000277140","volume":"73","author":"RP Grinspon","year":"2010","unstructured":"Grinspon RP, Rey RA (2010) Anti-m\u00fcllerian hormone and sertoli cell function in paediatric male hypogonadism. Horm Res Paediatr 73:81\u201392. https:\/\/doi.org\/10.1159\/000277140","journal-title":"Horm Res Paediatr"},{"key":"603_CR6","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.3390\/jcm11237209","volume":"11","author":"N Russell","year":"2022","unstructured":"Russell N, Gilmore A, Roudebush WE (2022) Clinical utilities of Anti-M\u00fcllerian hormone. J Clin Med 11:7209. https:\/\/doi.org\/10.3390\/jcm11237209","journal-title":"J Clin Med"},{"key":"603_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/jayao.2018.0130","volume":"8","author":"A-LLF van der Kooi","year":"2019","unstructured":"van der Kooi A-LLF, van den Heuvel-Eibrink MM, van den Berg SAA, van Dorp W, Pluijm SMF, Laven JSE (2019) Changes in Anti-M\u00fcllerian hormone and inhibin B in children treated for Cancer. J Adolesc Young Adult Oncol 8:281\u2013290. https:\/\/doi.org\/10.1089\/jayao.2018.0130","journal-title":"J Adolesc Young Adult Oncol"},{"key":"603_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1210\/clinem\/dgab687","volume":"107","author":"R Kanakatti Shankar","year":"2022","unstructured":"Kanakatti Shankar R, Dowlut-McElroy T, Dauber A, Gomez-Lobo V (2022) Clinical utility of anti-mullerian hormone in Pediatrics. J Clin Endocrinol Metab 107:309\u2013323. https:\/\/doi.org\/10.1210\/clinem\/dgab687","journal-title":"J Clin Endocrinol Metab"},{"key":"603_CR9","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.1210\/endo.140.12.7204","volume":"140","author":"AL Durlinger","year":"1999","unstructured":"Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP (1999) Control of primordial follicle recruitment by anti-M\u00fcllerian hormone in the mouse ovary. Endocrinology 140:5789\u20135796. https:\/\/doi.org\/10.1210\/endo.140.12.7204","journal-title":"Endocrinology"},{"key":"603_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.fertnstert.2013.08.052","volume":"101","author":"AJ Lunsford","year":"2014","unstructured":"Lunsford AJ, Whelan K, McCormick K, McLaren JF (2014) Antim\u00fcllerian hormone as a measure of reproductive function in female childhood cancer survivors. Fertil Steril 101:227\u2013231. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.08.052","journal-title":"Fertil Steril"},{"key":"603_CR11","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1080\/09513590.2021.1943344","volume":"37","author":"E Asanidze","year":"2021","unstructured":"Asanidze E, Kristesashvili J, Parunashvili N, Karelishvili N, Etsadashvili N (2021) Challenges in diagnosis of polycystic ovary syndrome in adolescence. Gynecol Endocrinol 37:819\u2013822. https:\/\/doi.org\/10.1080\/09513590.2021.1943344","journal-title":"Gynecol Endocrinol"},{"key":"603_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4274\/jcrpe.2338","volume":"8","author":"F Dursun","year":"2016","unstructured":"Dursun F, G\u00fcven A, Y\u0131ld\u0131z M (2016) Assessment of Anti-M\u00fcllerian hormone level in management of adolescents with polycystic ovary syndrome. J Clin Res Pediatr Endocrinol 8:55\u201360. https:\/\/doi.org\/10.4274\/jcrpe.2338","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"603_CR13","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4274\/jcrpe.3253","volume":"8","author":"A Yetim","year":"2016","unstructured":"Yetim A, Yetim \u00c7, Ba\u015f F, Erol OB, \u00c7\u0131\u011f G, U\u00e7ar A, Darendeliler F (2016) Anti-M\u00fcllerian hormone and Inhibin-A, but not Inhibin-B or insulin-like Peptide-3, may be used as surrogates in the diagnosis of polycystic ovary syndrome in adolescents: preliminary results. J Clin Res Pediatr Endocrinol 8:288\u2013297. https:\/\/doi.org\/10.4274\/jcrpe.3253","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"603_CR14","doi-asserted-by":"publisher","first-page":"e00021","DOI":"10.1002\/edm2.21","volume":"1","author":"H Jopling","year":"2018","unstructured":"Jopling H, Yates A, Burgoyne N, Hayden K, Chaloner C, Tetlow L (2018) Paediatric Anti-M\u00fcllerian hormone measurement: male and female reference intervals established using the automated Beckman Coulter Access AMH assay. Endocrinol Diabetes Metab 1:e00021. https:\/\/doi.org\/10.1002\/edm2.21","journal-title":"Endocrinol Diabetes Metab"},{"key":"603_CR15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1177\/0004563219830733","volume":"56","author":"AP Yates","year":"2019","unstructured":"Yates AP, Jopling HM, Burgoyne NJ, Hayden K, Chaloner CM, Tetlow L (2019) Paediatric reference intervals for plasma anti-M\u00fcllerian hormone: comparison of data from the Roche Elecsys assay and the Beckman Coulter Access assay using the same cohort of samples. Ann Clin Biochem 56:536\u2013547. https:\/\/doi.org\/10.1177\/0004563219830733","journal-title":"Ann Clin Biochem"},{"key":"603_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.clinbiochem.2022.06.005","volume":"108","author":"R Ronn","year":"2022","unstructured":"Ronn R, Bohn MK, Greenblatt EM, Hoffman B, Adeli K (2022) Anti-mullerian hormone (AMH) reference values in the CALIPER cohort of healthy community children and adolescents. Clin Biochem 108:63\u201366. https:\/\/doi.org\/10.1016\/j.clinbiochem.2022.06.005","journal-title":"Clin Biochem"},{"key":"603_CR17","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","volume":"390","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2017","unstructured":"NCD Risk Factor Collaboration (NCD-RisC) (2017) Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults. Lancet 390:2627\u20132642. https:\/\/doi.org\/10.1016\/S0140-6736(17)32129-3","journal-title":"Lancet"},{"key":"603_CR18","doi-asserted-by":"publisher","unstructured":"Czech I, Partyka M, Drosdzol-Cop A (2023) Does body mass index affect anti-mullerian hormone levels in girls and adolescents? Ginekol Pol. https:\/\/doi.org\/10.5603\/GP.a2023.0013","DOI":"10.5603\/GP.a2023.0013"},{"key":"603_CR19","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1507\/endocrj.EJ22-0081","volume":"69","author":"Y Tsukui","year":"2022","unstructured":"Tsukui Y, Kitahara Y, Hasegawa Y, Kobayashi M, Osuka S, Iwase A (2022) Anti-M\u00fcllerian hormone levels in the diagnosis of adolescent polycystic ovarian syndrome: a systematic review and meta-analysis. Endocr J 69:897\u2013906. https:\/\/doi.org\/10.1507\/endocrj.EJ22-0081","journal-title":"Endocr J"},{"key":"603_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12958-020-00676-y","volume":"18","author":"S Simpson","year":"2020","unstructured":"Simpson S, Seifer DB, Shabanova V, Lynn AY, Howe C, Rowe E, Caprio S, Vash-Margita A (2020) The association between anti-M\u00fcllerian hormone and vitamin 25(OH)D serum levels and polycystic ovarian syndrome in adolescent females. Reprod Biol Endocrinol 18:118. https:\/\/doi.org\/10.1186\/s12958-020-00676-y","journal-title":"Reprod Biol Endocrinol"},{"key":"603_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jadohealth.2016.10.015","volume":"60","author":"JY Kim","year":"2017","unstructured":"Kim JY, Tfayli H, Michaliszyn SF, Lee S, Nasr A, Arslanian S (2017) Anti-M\u00fcllerian hormone in obese adolescent girls with polycystic ovary syndrome. J Adolesc Health 60:333\u2013339. https:\/\/doi.org\/10.1016\/j.jadohealth.2016.10.015","journal-title":"J Adolesc Health"},{"key":"603_CR22","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.fertnstert.2009.11.002","volume":"94","author":"R Hart","year":"2010","unstructured":"Hart R, Doherty DA, Norman RJ, Franks S, Dickinson JE, Hickey M, Sloboda DM (2010) Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertil Steril 94:1118\u20131121. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.11.002","journal-title":"Fertil Steril"},{"key":"603_CR23","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.2147\/DMSO.S299558","volume":"14","author":"Y Ran","year":"2021","unstructured":"Ran Y, Yi Q, Li C (2021) The relationship of anti-mullerian hormone in polycystic ovary syndrome patients with different subgroups. Diabetes Metab Syndr Obes 14:1419\u20131424. https:\/\/doi.org\/10.2147\/DMSO.S299558","journal-title":"Diabetes Metab Syndr Obes"},{"key":"603_CR24","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jpag.2017.01.010","volume":"30","author":"T Chen","year":"2017","unstructured":"Chen T, Wu H, Xie R, Wang F, Chen X, Sun H, Chen L (2017) Serum Anti-M\u00fcllerian hormone and inhibin B as potential markers for progressive central precocious puberty in girls. J Pediatr Adolesc Gynecol 30:362\u2013366. https:\/\/doi.org\/10.1016\/j.jpag.2017.01.010","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"603_CR25","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1515\/jpem-2014-0521","volume":"28","author":"NM Sahin","year":"2015","unstructured":"Sahin NM, Kinik ST, Tekindal MA, Bayraktar N (2015) AMH levels at central precocious puberty and premature thelarche: is it a parameter? J Pediatr Endocrinol Metab 28:1351\u20131356. https:\/\/doi.org\/10.1515\/jpem-2014-0521","journal-title":"J Pediatr Endocrinol Metab"},{"key":"603_CR26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jpeds.2018.09.064","volume":"205","author":"A Efthymiadou","year":"2019","unstructured":"Efthymiadou A, Bogiatzidou M, Kritikou D, Chrysis D (2019) Anti-M\u00fcllerian hormone in girls with premature Adrenarche: the impact of polycystic ovary syndrome history in their mothers. J Pediatr 205:190\u2013194. https:\/\/doi.org\/10.1016\/j.jpeds.2018.09.064","journal-title":"J Pediatr"},{"key":"603_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4274\/jcrpe.galenos.2019.2018.0293","volume":"11","author":"N Murato\u011flu \u015eahin","year":"2019","unstructured":"Murato\u011flu \u015eahin N, Bayramo\u011flu E, Nursun \u00d6zcan H, Kurnaz E, Keskin M, Sava\u015f-Erdeve \u015e, \u00c7etinkaya S, Aycan Z (2019) Antim\u00fcllerian hormone levels of infants with premature Thelarche. J Clin Res Pediatr Endocrinol 11:287\u2013292. https:\/\/doi.org\/10.4274\/jcrpe.galenos.2019.2018.0293","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"603_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1210\/jcem.84.2.5507","volume":"84","author":"RA Rey","year":"1999","unstructured":"Rey RA, Belville C, Nihoul-F\u00e9k\u00e9t\u00e9 C, Michel-Calemard L, Forest MG, Lahlou N, Jaubert F, Mowszowicz I, David M, Saka N, Bouvattier C, Bertrand AM, Lecointre C, Soskin S, Cabrol S, Crosnier H, L\u00e9ger J, Lortat-Jacob S, Nicolino M, Rabl W, Toledo SP, Ba\u015f F, Gompel A, Czernichow P, Josso N (1999) Evaluation of gonadal function in 107 intersex patients by means of serum antim\u00fcllerian hormone measurement. J Clin Endocrinol Metab 84:627\u2013631. https:\/\/doi.org\/10.1210\/jcem.84.2.5507","journal-title":"J Clin Endocrinol Metab"},{"key":"603_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/humupd\/dmi014","volume":"11","author":"N Josso","year":"2005","unstructured":"Josso N, Belville C, di Clemente N, Picard J-Y (2005) AMH and AMH receptor defects in persistent M\u00fcllerian duct syndrome. Hum Reprod Update 11:351\u2013356. https:\/\/doi.org\/10.1093\/humupd\/dmi014","journal-title":"Hum Reprod Update"},{"key":"603_CR30","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1515\/jpem.2005.18.12.1383","volume":"18","author":"EG Stuchi-Perez","year":"2005","unstructured":"Stuchi-Perez EG, Hackel C, Oliveira LEC, Ferraz LFC, Oliveira LC, Nunes-Silva D, Toralles MB, Steinmetz L, Damiani D, Maciel-Guerra AT, Guerra-Junior G (2005) Diagnosis of 5alpha-reductase type 2 deficiency: contribution of anti-M\u00fcllerian hormone evaluation. J Pediatr Endocrinol Metab 18:1383\u20131389. https:\/\/doi.org\/10.1515\/jpem.2005.18.12.1383","journal-title":"J Pediatr Endocrinol Metab"},{"key":"603_CR31","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1210\/jcem.79.4.7962305","volume":"79","author":"R Rey","year":"1994","unstructured":"Rey R, Mebarki F, Forest MG, Mowszowicz I, Cate RL, Morel Y, Chaussain JL, Josso N (1994) Anti-m\u00fcllerian hormone in children with androgen insensitivity. J Clin Endocrinol Metab 79:960\u2013964. https:\/\/doi.org\/10.1210\/jcem.79.4.7962305","journal-title":"J Clin Endocrinol Metab"},{"key":"603_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12958-020-00593-0","volume":"18","author":"Q Liu","year":"2020","unstructured":"Liu Q, Yin X, Li P (2020) Clinical, hormonal and genetic characteristics of androgen insensitivity syndrome in 39 Chinese patients. Reprod Biol Endocrinol 18:34. https:\/\/doi.org\/10.1186\/s12958-020-00593-0","journal-title":"Reprod Biol Endocrinol"},{"key":"603_CR33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ejogrb.2020.08.011","volume":"253","author":"S Chen","year":"2020","unstructured":"Chen S, Yang B, Fan J (2020) Diagnostic value of anti-mullerian hormone in ovarian granulosa cell tumor: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 253:266\u2013272. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.08.011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"603_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13048-023-01134-0","volume":"16","author":"M Kitajima","year":"2023","unstructured":"Kitajima M, Kajimura I, Kitajima Y, Murakami N, Matsumura A, Matsumoto K, Harada A, Hasegawa Y, Miura K (2023) AMH producing purely cystic virilizing adult granulosa cell tumor in 17 years old girl: a case report and review of literatures. J Ovarian Res 16:52. https:\/\/doi.org\/10.1186\/s13048-023-01134-0","journal-title":"J Ovarian Res"},{"key":"603_CR35","doi-asserted-by":"publisher","first-page":"e2021319","DOI":"10.23750\/abm.v92i4.11572","volume":"92","author":"V De Sanctis","year":"2021","unstructured":"De Sanctis V, Ahmed S, Soliman A, Alyafei F, Alaaraj N, Al Maadheed M, Clelland C (2021) A rare case of ovarian juvenile Granulosa Cell Tumor in an infant with Isosexual Pseudo Puberty and a revision of literature. Acta Biomed 92:e2021319. https:\/\/doi.org\/10.23750\/abm.v92i4.11572","journal-title":"Acta Biomed"},{"key":"603_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1089\/jayao.2018.0080","volume":"8","author":"SA George","year":"2019","unstructured":"George SA, Williamson Lewis R, Schirmer DA, Effinger KE, Spencer JB, Mertens AC, Meacham LR (2019) Early detection of ovarian dysfunction by anti-mullerian hormone in adolescent and young adult-aged survivors of Childhood Cancer. J Adolesc Young Adult Oncol 8:18\u201325. https:\/\/doi.org\/10.1089\/jayao.2018.0080","journal-title":"J Adolesc Young Adult Oncol"},{"key":"603_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/humupd\/dmac004","volume":"28","author":"RA Anderson","year":"2022","unstructured":"Anderson RA, Cameron D, Clatot F, Demeestere I, Lambertini M, Nelson SM, Peccatori F (2022) Anti-M\u00fcllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review. Hum Reprod Update 28:417\u2013434. https:\/\/doi.org\/10.1093\/humupd\/dmac004","journal-title":"Hum Reprod Update"},{"key":"603_CR38","doi-asserted-by":"publisher","unstructured":"Wang J, Lan T, Dai X, Yang L, Hu X, Yao H (2023) The Cut-Off Value of Serum Anti-M\u00fcllerian Hormone Levels for the Diagnosis of Turner Syndrome with Spontaneous Puberty. Int J Endocrinol 2023:6976389. https:\/\/doi.org\/10.1155\/2023\/6976389","DOI":"10.1155\/2023\/6976389"},{"key":"603_CR39","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1093\/humrep\/det089","volume":"28","author":"JA Visser","year":"2013","unstructured":"Visser JA, Hokken-Koelega ACS, Zandwijken GRJ, Limacher A, Ranke MB, Fl\u00fcck CE (2013) Anti-M\u00fcllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment. Hum Reprod 28:1899\u20131907. https:\/\/doi.org\/10.1093\/humrep\/det089","journal-title":"Hum Reprod"},{"key":"603_CR40","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/ajmg.a.40473","volume":"176","author":"RT Hamza","year":"2018","unstructured":"Hamza RT, Mira MF, Hamed AI, Ezzat T, Sallam MT (2018) Anti-M\u00fcllerian hormone levels in patients with turner syndrome: relation to karyotype, spontaneous puberty, and replacement therapy. Am J Med Genet A 176:1929\u20131934. https:\/\/doi.org\/10.1002\/ajmg.a.40473","journal-title":"Am J Med Genet A"},{"key":"603_CR41","doi-asserted-by":"publisher","first-page":"E1030","DOI":"10.1210\/jc.2015-1621","volume":"100","author":"SA Lunding","year":"2015","unstructured":"Lunding SA, Aksglaede L, Anderson RA, Main KM, Juul A, Hagen CP, Pedersen AT (2015) AMH as Predictor of premature ovarian insufficiency: a longitudinal study of 120 Turner Syndrome patients. J Clin Endocrinol Metab 100:E1030\u20131038. https:\/\/doi.org\/10.1210\/jc.2015-1621","journal-title":"J Clin Endocrinol Metab"},{"key":"603_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14971","author":"VH Bustamante","year":"2023","unstructured":"Bustamante VH, Galetaki DM, Dowlut-McElroy T, Kanakatti Shankar R (2023) Anti-mullerian hormone and spontaneous puberty in a diverse US Turner syndrome clinic cohort: a cross-sectional study. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/cen.14971","journal-title":"Clin Endocrinol (Oxf)"},{"key":"603_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2265.2010.03887.x","volume":"74","author":"E Codner","year":"2011","unstructured":"Codner E, I\u00f1iguez G, Hern\u00e1ndez IM, Lopez P, Rhumie HK, Villarroel C, Rey RA (2011) Elevated anti-M\u00fcllerian hormone (AMH) and inhibin B levels in prepubertal girls with type 1 diabetes mellitus. Clin Endocrinol (Oxf) 74:73\u201378. https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03887.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"603_CR44","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jpag.2014.01.002","volume":"27","author":"ICdaS Bouzas","year":"2014","unstructured":"Bouzas ICdaS, Cader SA, Le\u00e3o L, Kuschnir MC, Braga C (2014) Menstrual cycle alterations during adolescence: early expression of metabolic syndrome and polycystic ovary syndrome. J Pediatr Adolesc Gynecol 27:335\u2013341. https:\/\/doi.org\/10.1016\/j.jpag.2014.01.002","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"603_CR45","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-14-0253","volume":"171","author":"G Conway","year":"2014","unstructured":"Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D, Pasquali R, Pfeifer M, Pignatelli D, Pugeat M, Yildiz BO, ESE PCOS Special Interest Group (2014) The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 171:P1\u201329. https:\/\/doi.org\/10.1530\/EJE-14-0253","journal-title":"Eur J Endocrinol"},{"key":"603_CR46","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12958-015-0134-9","volume":"13","author":"A Dumont","year":"2015","unstructured":"Dumont A, Robin G, Catteau-Jonard S, Dewailly D (2015) Role of Anti-M\u00fcllerian hormone in pathophysiology, diagnosis and treatment of polycystic ovary syndrome: a review. Reprod Biol Endocrinol 13:137. https:\/\/doi.org\/10.1186\/s12958-015-0134-9","journal-title":"Reprod Biol Endocrinol"},{"key":"603_CR47","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1210\/jc.2009-0544","volume":"94","author":"M Hickey","year":"2009","unstructured":"Hickey M, Sloboda DM, Atkinson HC, Doherty DA, Franks S, Norman RJ, Newnham JP, Hart R (2009) The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. J Clin Endocrinol Metab 94:3714\u20133720. https:\/\/doi.org\/10.1210\/jc.2009-0544","journal-title":"J Clin Endocrinol Metab"},{"key":"603_CR48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s13224-020-01362-0","volume":"70","author":"L Shrikhande","year":"2020","unstructured":"Shrikhande L, Shrikhande B, Shrikhande A (2020) AMH and its clinical implications. J Obstet Gynaecol India 70:337\u2013341. https:\/\/doi.org\/10.1007\/s13224-020-01362-0","journal-title":"J Obstet Gynaecol India"},{"key":"603_CR49","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jpag.2018.02.126","volume":"31","author":"P Kocaay","year":"2018","unstructured":"Kocaay P, Siklar Z, Buyukfirat S, Berberoglu M (2018) The diagnostic value of Anti-M\u00fcllerian hormone in early Post Menarche adolescent girls with polycystic ovarian syndrome. J Pediatr Adolesc Gynecol 31:362\u2013366. https:\/\/doi.org\/10.1016\/j.jpag.2018.02.126","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"603_CR50","doi-asserted-by":"publisher","DOI":"10.1159\/000375530","author":"SF Witchel","year":"2015","unstructured":"Witchel SF, Oberfield S, Rosenfield RL, Codner E, Bonny A, Ib\u00e1\u00f1ez L, Pena A, Horikawa R, Gomez-Lobo V, Joel D, Tfayli H, Arslanian S, Dabadghao P, Garcia Rudaz C, Lee PA (2015) The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr. https:\/\/doi.org\/10.1159\/000375530","journal-title":"Horm Res Paediatr"},{"key":"603_CR51","doi-asserted-by":"publisher","first-page":"731","DOI":"10.4103\/2230-8210.167548","volume":"19","author":"AK Singh","year":"2015","unstructured":"Singh AK, Singh R (2015) Can anti-mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress. Indian J Endocrinol Metab 19:731\u2013743. https:\/\/doi.org\/10.4103\/2230-8210.167548","journal-title":"Indian J Endocrinol Metab"},{"key":"603_CR52","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.tem.2019.04.006","volume":"30","author":"H Teede","year":"2019","unstructured":"Teede H, Misso M, Tassone EC, Dewailly D, Ng EH, Azziz R, Norman RJ, Andersen M, Franks S, Hoeger K, Hutchison S, Oberfield S, Shah D, Hohmann F, Ottey S, Dabadghao P, Laven JSE (2019) Anti-M\u00fcllerian hormone in PCOS: a Review Informing International guidelines. Trends Endocrinol Metab 30:467\u2013478. https:\/\/doi.org\/10.1016\/j.tem.2019.04.006","journal-title":"Trends Endocrinol Metab"},{"key":"603_CR53","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1210\/jc.2007-0267","volume":"92","author":"N Crisosto","year":"2007","unstructured":"Crisosto N, Codner E, Maliqueo M, Echibur\u00fa B, S\u00e1nchez F, Cassorla F, Sir-Petermann T (2007) Anti-M\u00fcllerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 92:2739\u20132743. https:\/\/doi.org\/10.1210\/jc.2007-0267","journal-title":"J Clin Endocrinol Metab"},{"key":"603_CR54","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fped.2019.00147","volume":"7","author":"G Farello","year":"2019","unstructured":"Farello G, Altieri C, Cutini M, Pozzobon G, Verrotti A (2019) Review of the literature on current changes in the timing of Pubertal Development and the incomplete forms of early puberty. Front Pediatr 7:147. https:\/\/doi.org\/10.3389\/fped.2019.00147","journal-title":"Front Pediatr"},{"key":"603_CR55","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1542\/peds.2005-0012","volume":"116","author":"G Teilmann","year":"2005","unstructured":"Teilmann G, Pedersen CB, Jensen TK, Skakkebaek NE, Juul A (2005) Prevalence and incidence of precocious pubertal development in Denmark: an epidemiologic study based on national registries. Pediatrics 116:1323\u20131328. https:\/\/doi.org\/10.1542\/peds.2005-0012","journal-title":"Pediatrics"},{"key":"603_CR56","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.fertnstert.2013.01.139","volume":"99","author":"H Lashen","year":"2013","unstructured":"Lashen H, Dunger DB, Ness A, Ong KK (2013) Peripubertal changes in circulating antim\u00fcllerian hormone levels in girls. Fertil Steril 99:2071\u20132075. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.01.139","journal-title":"Fertil Steril"},{"key":"603_CR57","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.xfre.2021.02.001","volume":"2","author":"MB Smith","year":"2021","unstructured":"Smith MB, Ho J, Ma L, Lee M, Czerwinski SA, Glenn TL, Cool DR, Gagneux P, Stanczyk FZ, McGinnis LK, Lindheim SR (2021) Longitudinal antim\u00fcllerian hormone and its correlation with pubertal milestones. F S Rep 2:238\u2013244. https:\/\/doi.org\/10.1016\/j.xfre.2021.02.001","journal-title":"F S Rep"},{"key":"603_CR58","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1080\/09513590.2020.1718642","volume":"36","author":"HR Jeong","year":"2020","unstructured":"Jeong HR, Lee HJ, Shim YS, Kang MJ, Yang S, Hwang IT (2020) Inhibin B as a screening tool for early detection and treatment monitoring of central precocious puberty. Gynecol Endocrinol 36:768\u2013771. https:\/\/doi.org\/10.1080\/09513590.2020.1718642","journal-title":"Gynecol Endocrinol"},{"key":"603_CR59","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1515\/jpem-2016-0217","volume":"30","author":"S Savas-Erdeve","year":"2017","unstructured":"Savas-Erdeve S, Sagsak E, Keskin M, Cetinkaya S, Aycan Z (2017) AMH levels in girls with various pubertal problems. J Pediatr Endocrinol Metab 30:333\u2013335. https:\/\/doi.org\/10.1515\/jpem-2016-0217","journal-title":"J Pediatr Endocrinol Metab"},{"key":"603_CR60","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.fertnstert.2012.07.1118","volume":"98","author":"CP Hagen","year":"2012","unstructured":"Hagen CP, S\u00f8rensen K, Anderson RA, Juul A (2012) Serum levels of antim\u00fcllerian hormone in early maturing girls before, during, and after suppression with GnRH agonist. Fertil Steril 98:1326\u20131330. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.07.1118","journal-title":"Fertil Steril"},{"key":"603_CR61","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3346\/jkms.2017.32.3.475","volume":"32","author":"HK Nam","year":"2017","unstructured":"Nam HK, Kim HR, Rhie YJ, Lee KH (2017) Serum Anti-M\u00fcllerian hormone levels in precocious puberty girls according to stage of GnRH agonist treatment. J Korean Med Sci 32:475\u2013479. https:\/\/doi.org\/10.3346\/jkms.2017.32.3.475","journal-title":"J Korean Med Sci"},{"key":"603_CR62","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/cen.14906","volume":"98","author":"D Vuralli","year":"2023","unstructured":"Vuralli D, Ciftci N, Demirbilek H (2023) Serum kisspeptin, neurokinin B and inhibin B levels can be used as alternative parameters to distinguish idiopathic CPP from premature thelarche in the early stages of puberty. Clin Endocrinol (Oxf) 98:788\u2013795. https:\/\/doi.org\/10.1111\/cen.14906","journal-title":"Clin Endocrinol (Oxf)"},{"key":"603_CR63","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.clp.2021.11.013","volume":"49","author":"NG Allen","year":"2022","unstructured":"Allen NG, Krishna KB, Lee PA (2022) Differences of Sex Development: what neonatologists need to know. Clin Perinatol 49:207\u2013218. https:\/\/doi.org\/10.1016\/j.clp.2021.11.013","journal-title":"Clin Perinatol"},{"key":"603_CR64","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.beem.2007.11.001","volume":"22","author":"IA Hughes","year":"2008","unstructured":"Hughes IA (2008) Disorders of sex development: a new definition and classification. Best Pract Res Clin Endocrinol Metab 22:119\u2013134. https:\/\/doi.org\/10.1016\/j.beem.2007.11.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"603_CR65","doi-asserted-by":"publisher","unstructured":"Guerrero-Fern\u00e1ndez J, Azcona San Juli\u00e1n C, Barreiro Conde J, de la Berm\u00fadez JA, Carcavilla Urqu\u00ed A, Casta\u00f1o Gonz\u00e1lez LA, Martos Tello JM, Rodr\u00edguez Est\u00e9vez A, Yeste Fern\u00e1ndez D, Mart\u00ednez Mart\u00ednez L, Mart\u00ednez-Urrutia MJ, Mora Palma C, Aud\u00ed, Parera L (2018) [Management guidelines for disorders \/ different sex development (DSD)]. An Pediatr (Engl Ed) 89:315.e1-315.e19. https:\/\/doi.org\/10.1016\/j.anpedi.2018.06.009","DOI":"10.1016\/j.anpedi.2018.06.009"},{"key":"603_CR66","doi-asserted-by":"publisher","first-page":"14408","DOI":"10.3390\/ijms232214408","volume":"23","author":"B Lamanna","year":"2022","unstructured":"Lamanna B, Vinciguerra M, Dellino M, Cascella G, Cazzato G, Macorano E, Malvasi A, Scacco S, Cicinelli E, Loizzi V, Vimercati A, Cormio G, Paduano F, Cascardi E, Tatullo M (2022) Turner Syndrome Mosaicism 45,X\/46,XY with genital ambiguity and duchenne muscular dystrophy: Translational Approach of a rare Italian case. Int J Mol Sci 23:14408. https:\/\/doi.org\/10.3390\/ijms232214408","journal-title":"Int J Mol Sci"},{"key":"603_CR67","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3389\/fendo.2020.00619","volume":"11","author":"N Josso","year":"2020","unstructured":"Josso N, Rey RA (2020) What does AMH tell us in Pediatric disorders of Sex Development? Front Endocrinol (Lausanne) 11:619. https:\/\/doi.org\/10.3389\/fendo.2020.00619","journal-title":"Front Endocrinol (Lausanne)"},{"key":"603_CR68","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1210\/jc.2003-031624","volume":"89","author":"N Lahlou","year":"2004","unstructured":"Lahlou N, Fennoy I, Carel J-C, Roger M (2004) Inhibin B and anti-M\u00fcllerian hormone, but not testosterone levels, are normal in infants with nonmosaic Klinefelter syndrome. J Clin Endocrinol Metab 89:1864\u20131868. https:\/\/doi.org\/10.1210\/jc.2003-031624","journal-title":"J Clin Endocrinol Metab"},{"key":"603_CR69","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000519323","volume":"96","author":"H Syryn","year":"2023","unstructured":"Syryn H, Van De Vijver K, Cools M (2023) Ovotesticular Difference of Sex Development: genetic background, histological features, and Clinical Management. Horm Res Paediatr 96:180\u2013189. https:\/\/doi.org\/10.1159\/000519323","journal-title":"Horm Res Paediatr"},{"key":"603_CR70","doi-asserted-by":"publisher","first-page":"919670","DOI":"10.3389\/fendo.2022.919670","volume":"13","author":"AK Lucas-Herald","year":"2022","unstructured":"Lucas-Herald AK, Mitchell RT (2022) Testicular sertoli cell hormones in differences in Sex Development. Front Endocrinol (Lausanne) 13:919670. https:\/\/doi.org\/10.3389\/fendo.2022.919670","journal-title":"Front Endocrinol (Lausanne)"},{"key":"603_CR71","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000475516","volume":"11","author":"J-Y Picard","year":"2017","unstructured":"Picard J-Y, Cate RL, Racine C, Josso N (2017) The Persistent M\u00fcllerian Duct Syndrome: an update based upon a personal experience of 157 cases. Sex Dev 11:109\u2013125. https:\/\/doi.org\/10.1159\/000475516","journal-title":"Sex Dev"},{"key":"603_CR72","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00404-017-4596-1","volume":"297","author":"M Henes","year":"2018","unstructured":"Henes M, Jurow L, Peter A, Schoenfisch B, Taran FA, Huebner M, Seeger H, Brucker SY, Rall KK (2018) Hyperandrogenemia and ovarian reserve in patients with Mayer-Rokitansky-K\u00fcster-Hauser syndrome type 1 and 2: potential influences on ovarian stimulation. Arch Gynecol Obstet 297:513\u2013520. https:\/\/doi.org\/10.1007\/s00404-017-4596-1","journal-title":"Arch Gynecol Obstet"},{"key":"603_CR73","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1530\/EC-18-0376","volume":"8","author":"LA Hughes","year":"2019","unstructured":"Hughes LA, McKay-Bounford K, Webb EA, Dasani P, Clokie S, Chandran H, McCarthy L, Mohamed Z, Kirk JMW, Krone NP, Allen S, Cole TRP (2019) Next generation sequencing (NGS) to improve the diagnosis and management of patients with disorders of sex development (DSD). Endocr Connect 8:100\u2013110. https:\/\/doi.org\/10.1530\/EC-18-0376","journal-title":"Endocr Connect"},{"key":"603_CR74","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.1016\/S1470-2045(20)30091-7","volume":"21","author":"C Sessa","year":"2020","unstructured":"Sessa C, Schneider DT, Planchamp F, Baust K, Braicu EI, Concin N, Godzinski J, McCluggage WG, Orbach D, Pautier P, Peccatori FA, Morice P, Calaminus G (2020) ESGO-SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers. Lancet Oncol 21:e360\u2013e368. https:\/\/doi.org\/10.1016\/S1470-2045(20)30091-7","journal-title":"Lancet Oncol"},{"key":"603_CR75","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3390\/children10071114","volume":"10","author":"E Birbas","year":"2023","unstructured":"Birbas E, Kanavos T, Gkrozou F, Skentou C, Daniilidis A, Vatopoulou A (2023) Ovarian masses in children and adolescents: a review of the literature with emphasis on the Diagnostic Approach. Child (Basel) 10:1114. https:\/\/doi.org\/10.3390\/children10071114","journal-title":"Child (Basel)"},{"key":"603_CR76","doi-asserted-by":"publisher","first-page":"198698","DOI":"10.1155\/2013\/198698","volume":"2013","author":"M Lindhardt Johansen","year":"2013","unstructured":"Lindhardt Johansen M, Hagen CP, Johannsen TH, Main KM, Picard J-Y, J\u00f8rgensen A, Rajpert-De Meyts E, Juul A (2013) Anti-m\u00fcllerian hormone and its clinical use in pediatrics with special emphasis on disorders of sex development. Int J Endocrinol 2013:198698. https:\/\/doi.org\/10.1155\/2013\/198698","journal-title":"Int J Endocrinol"},{"key":"603_CR77","doi-asserted-by":"publisher","first-page":"1173600","DOI":"10.3389\/fendo.2023.1173600","volume":"14","author":"CP Hagen","year":"2023","unstructured":"Hagen CP, Fischer MB, Mola G, Mikkelsen TB, Cleemann LH, Gravholt CH, Viuff MH, Juul A, Pedersen AT, Main KM (2023) AMH and other markers of ovarian function in patients with Turner syndrome - a single center experience of transition from pediatric to gynecological follow up. Front Endocrinol (Lausanne) 14:1173600. https:\/\/doi.org\/10.3389\/fendo.2023.1173600","journal-title":"Front Endocrinol (Lausanne)"},{"key":"603_CR78","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/mi14010151","volume":"14","author":"SM Rodrigues Oliveira","year":"2023","unstructured":"Rodrigues Oliveira SM, Rebocho A, Ahmadpour E, Nissapatorn V, de Lourdes Pereira M (2023) Type 1 diabetes Mellitus: a review on advances and challenges in creating insulin producing devices. Micromachines (Basel) 14:151. https:\/\/doi.org\/10.3390\/mi14010151","journal-title":"Micromachines (Basel)"},{"key":"603_CR79","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1001\/jama.2014.3201","volume":"311","author":"D Dabelea","year":"2014","unstructured":"Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, Bell R, Badaru A, Talton JW, Crume T, Liese AD, Merchant AT, Lawrence JM, Reynolds K, Dolan L, Liu LL, Hamman RF, SEARCH for Diabetes in Youth Study (2014) Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 311:1778\u20131786. https:\/\/doi.org\/10.1001\/jama.2014.3201","journal-title":"JAMA"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00603-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-024-00603-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00603-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T12:53:23Z","timestamp":1742216003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-024-00603-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["603"],"URL":"https:\/\/doi.org\/10.1007\/s42000-024-00603-5","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}